Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 392 participants.
Also called NCT02944734
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 392 participants
- Registry
-
NCT02944734
-
- Other papers using this trial's data
- Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02944734. Randomized; quadruple masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2015-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension
- Condition
- Essential Hypertension
- Intervention (Drug)
- Candesartan Cilexetil 8mg
- Intervention (Drug)
- Candesartan Cilexetil 16mg
- Intervention (Drug)
- Amlodipine 5mg
- Intervention (Drug)
- Amlodipine 10mg
- Lead sponsor
- Shin Poong Pharmaceutical Co. Ltd.
Record details
- Record id
cardio:ct-nct02944734- Content hash
9b3bae408541b66ae52eae325e024b120f653a2a95dfc8e8db8a7f15fcfe20ab